Axsome Therapeutics (AXSM) Leases (2022 - 2025)
Historic Leases for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $21.7 million.
- Axsome Therapeutics' Leases rose 27790.58% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.7 million, marking a year-over-year increase of 27790.58%. This contributed to the annual value of $5.4 million for FY2024, which is 2051.09% down from last year.
- Per Axsome Therapeutics' latest filing, its Leases stood at $21.7 million for Q3 2025, which was up 27790.58% from $22.5 million recorded in Q2 2025.
- Axsome Therapeutics' Leases' 5-year high stood at $23.3 million during Q1 2025, with a 5-year trough of $106000.0 in Q1 2023.
- In the last 4 years, Axsome Therapeutics' Leases had a median value of $6.1 million in 2024 and averaged $7.7 million.
- As far as peak fluctuations go, Axsome Therapeutics' Leases tumbled by 8880.06% in 2023, and later surged by 594811.32% in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Leases stood at $420000.0 in 2022, then surged by 1512.38% to $6.8 million in 2023, then decreased by 20.51% to $5.4 million in 2024, then skyrocketed by 302.27% to $21.7 million in 2025.
- Its last three reported values are $21.7 million in Q3 2025, $22.5 million for Q2 2025, and $23.3 million during Q1 2025.